Drug Pipeline

HRS9531 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
3
Phase 3
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-06 NCT07551492
A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With…		 Recruitment opened
Active Studies by Phase
Phase 3
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07060456 Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal… Type 2 Diabetes Recruiting
NCT06994650 A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to… Subjects With Moderate-to-severe OSA and Obesity Who Are on PAP Therapy Recruiting
NCT07551492 A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With… Atherosclerotic Cardiovascular Disease Recruiting
Sponsors Running HRS9531 Trials
Fujian Shengdi Pharmaceutical Co., Ltd. (3)
Disease Areas
Obesity (1) Type 2 Diabetes (1) Diabetes (1) Heart Disease (1)
Get alerts when HRS9531 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free